ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JEAN-CLAUDE PROVOST FNP-C

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,294Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 288

$393K Total Retail Price of All Prescriptions

Rank: 11 out of 288

206 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 206 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

20% of this provider’s 206 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,424 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
AMLODIPINE BESYLATE 323 300 1 7
LISINOPRIL 321 315 2 1
FUROSEMIDE 315 302 3 8
OMEPRAZOLE 277 265 4 4
LEVOTHYROXINE SODIUM 244 232 5 2
CITALOPRAM HBR 241 229 6 12
MELOXICAM 228 214 7 37
WARFARIN SODIUM 205 124 8 11
NAMENDA 201 201 9 30
HYDROCODONE-ACETAMINOPHEN 169 128 S3 10 3
SIMVASTATIN 159 147 11 5
DONEPEZIL HCL 158 157 12 29
TRAZODONE HCL 158 141 12 13
METOPROLOL TARTRATE 155 142 14 15
DIVALPROEX SODIUM 140 118 15 32
MIRTAZAPINE 125 125 16 43
POLYETHYLENE GLYCOL 3350 124 113 17 48
SERTRALINE HCL 116 112 18 23
POTASSIUM CHLORIDE 113 100 19 18
VENLAFAXINE HCL ER 97 97 20 59
OLANZAPINE 92 83 21 79
FLUCONAZOLE 87 85 22 112
QUETIAPINE FUMARATE 84 67 23 42
METFORMIN HCL 78 66 24 6
GABAPENTIN 78 78 24 10
LOVASTATIN 73 63 26 14
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 65 27 93
HYDROCHLOROTHIAZIDE 69 45 28 9
LOSARTAN POTASSIUM 69 62 28 19
RISPERIDONE 68 53 30 40
ESCITALOPRAM OXALATE 63 60 31 61
ADVAIR DISKUS 62 55 32 38
ALENDRONATE SODIUM 60 58 33 34
TAMSULOSIN HCL 58 34 34 50
FLUOXETINE HCL 58 33 34 36
ATENOLOL 58 46 34 15
ABILIFY 56 54 37 114
LAMOTRIGINE 56 53 37 64
CHLORHEXIDINE GLUCONATE 52 46 39 188
OXYCODONE-ACETAMINOPHEN 50 23 S2 40 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.